Evidence map›Paper›PMID 37204080›Full record

ArticleMolecular genetics & genomic medicine2023

Genetic analysis and outcomes of Omani children with steroid-resistant nephrotic syndrome.

Mohamed S Al Riyami, Intisar Al Alawi, Badria Al Gaithi, Anisa Al Maskari, Naifain Al Kalbani, Nadia Al Hashmi, Aisha Al Balushi, Maryam Al Shahi, Suliman Al Saidi, Muna Al Bimani and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Congenital Nephrotic Syndrome in Oman:Sultan Qaboos University medical journal · 2026
    Article
  5. Nucleoporin-associated steroid-resistant nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Mohamed S Al RiyamiPediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat, Oman.ORCID 0000-0003-3698-5609
Intisar Al AlawiTranslational and Clinical Research Institute, Faculty of Medical Science, Newcastle University, Newcastle upon Tyne, UK.
Badria Al GaithiPediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat, Oman.
Anisa Al MaskariPediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat, Oman.
Naifain Al KalbaniPediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat, Oman.
Nadia Al HashmiPediatric Metabolic and Genetic Disorder Unit, Royal Hospital, Muscat, Oman.
Aisha Al BalushiPediatric Metabolic and Genetic Disorder Unit, Royal Hospital, Muscat, Oman.
Maryam Al ShahiPediatric Clinical Genetic Unit, Royal Hospital, Department of Child Health, Royal Hospital, Muscat, Oman.
Suliman Al SaidiPediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat, Oman.
Muna Al BimaniNational Genetic Center, Ministry of Health, Muscat, Oman.
Fahad Al HataliNational Genetic Center, Ministry of Health, Muscat, Oman.
Holly MabillardTranslational and Clinical Research Institute, Faculty of Medical Science, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0001-6725-7570
John A SayerTranslational and Clinical Research Institute, Faculty of Medical Science, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0003-1881-3782
Royal Hospital · OMMinistry of Health · OMNewcastle upon Tyne Hospitals NHS Foundation Trust · GB

Funding

Medical Research Council MR/V028723/1Medical Research Council MR/Y007808/1
6 · The paper itself

Abstract

backgroundNephrotic syndrome (NS) is one of the most common kidney disorders seen by pediatric nephrologists and is defined by the presence of heavy proteinuria (>3.5 g/24 h), hypoalbuminemia (<3.5 g/dL), edema, and hyperlipidemia. Most children with NS are steroid-responsive and have a good prognosis following treatment with prednisolone. However, 10%-20% of them have steroid-resistant nephrotic syndrome (SRNS) and fail to respond to treatment. A significant proportion of these children progress to kidney failure.

methodsThis retrospective study aimed to determine the underlying genetic causes of SRNS among Omani children below 13 years old, over a 15-year period and included 77 children from 50 different families. We used targeted Sanger sequencing combined with next-generation sequencing approaches to perform molecular diagnostics.

resultsWe found a high rate of underlying genetic causes of SRNS in 61 (79.2%) children with pathogenic variants in the associated genes. Most of these genetically solved SRNS patients were born to consanguineous parents and variants were in the homozygous state. Pathogenic variants in NPHS2 were the most common cause of SRNS in our study seen in 37 (48.05%) cases. Pathogenic variants in NPHS1 were also seen in 16 cases, especially in infants with congenital nephrotic syndrome (CNS). Other genetic causes identified included pathogenic variants in LAMB2, PLCE1, MYO1E, and NUP93.

conclusionNPHS2 and NPHS1 genetic variants were the most common inherited causes of SRNS in Omani children. However, patients with variants in several other SRNS causative genes were also identified. We recommend screening for all genes responsible for SRNS in all children who present with this phenotype, which will assist in clinical management decisions and genetic counseling for the affected families.

Indexed as

Nephrotic SyndromeAdolescentChildDNA Mutational AnalysisGenetic Predisposition to DiseaseHumansInfantMembrane ProteinsRetrospective StudiesMembrane Proteinsedemahyperlipidemiahypoalbuminemiakidney failureproteinuriasteroid-resistant nephrotic syndrome

Identifiers

PMID37204080
PMCPMC10496054
OpenAlexW4377094258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.